The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Glucagonoma


High impact information on Glucagonoma


Chemical compound and disease context of Glucagonoma


Biological context of Glucagonoma


Anatomical context of Glucagonoma


Gene context of Glucagonoma


Analytical, diagnostic and therapeutic context of Glucagonoma


  1. Secretion by glucagonomas of a possible glucagon precursor. Weir, G.C., Horton, E.S., Aoki, T.T., Slovik, D., Jaspan, J., Rubenstein, A.H. J. Clin. Invest. (1977) [Pubmed]
  2. Transthyretin in endocrine pancreatic tumors. Jacobsson, B., Carlström, A., Collins, V.P., Grimelius, L. Am. J. Pathol. (1989) [Pubmed]
  3. Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma. Holmes, A., Kilpatrick, C., Proietto, J., Green, M.D. Am. J. Med. (1991) [Pubmed]
  4. Clinical and metabolic aspects of glucagonoma. Leichter, S.B. Medicine (Baltimore) (1980) [Pubmed]
  5. Slow-release lanreotide treatment in endocrine gastrointestinal tumors. Tomassetti, P., Migliori, M., Gullo, L. Am. J. Gastroenterol. (1998) [Pubmed]
  6. Cholecystokinin and glucagonoma. Philippe, J., Powers, A.C., Brand, S.J. N. Engl. J. Med. (1988) [Pubmed]
  7. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. Boden, G., Ryan, I.G., Eisenschmid, B.L., Shelmet, J.J., Owen, O.E. N. Engl. J. Med. (1986) [Pubmed]
  8. Familial hyperglucagonemia--an autosomal dominant disorder. Boden, G., Owen, O.E. N. Engl. J. Med. (1977) [Pubmed]
  9. Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. Jensen, P.B., Blume, N., Mikkelsen, J.D., Larsen, P.J., Jensen, H.I., Holst, J.J., Madsen, O.D. J. Clin. Invest. (1998) [Pubmed]
  10. Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Efrat, S., Teitelman, G., Anwar, M., Ruggiero, D., Hanahan, D. Neuron (1988) [Pubmed]
  11. Successful treatment of metastatic glucagonoma with dacarbazine. Kurose, T., Seino, Y., Ishida, H., Fujita, J., Taminato, T., Matsukura, M., Imura, H. Lancet (1984) [Pubmed]
  12. Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells. Ronner, P., Matschinsky, F.M., Hang, T.L., Epstein, A.J., Buettger, C. Diabetes (1993) [Pubmed]
  13. Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon. Jones, D.V., Samaan, N.A., Sellin, R.V., Ajani, J.A. Am. J. Med. (1992) [Pubmed]
  14. Protein metabolism in glucagonoma. Barazzoni, R., Zanetti, M., Tiengo, A., Tessari, P. Diabetologia (1999) [Pubmed]
  15. Islet amyloid polypeptide and insulin expression are controlled differently in primary and transformed islet cells. Madsen, O.D., Nielsen, J.H., Michelsen, B., Westermark, P., Betsholtz, C., Nishi, M., Steiner, D.F. Mol. Endocrinol. (1991) [Pubmed]
  16. Anaesthetic management of glucagonoma. Nicoll, J.M., Catling, S.J. Anaesthesia. (1985) [Pubmed]
  17. Amino acid, glucose, and lipid kinetics after palliative resection in a patient with glucagonoma syndrome. Bernstein, M., Jahoor, F., Townsend, C.M., Klein, S. Metab. Clin. Exp. (2001) [Pubmed]
  18. Transcription factors contributing to the pancreatic beta-cell phenotype. Madsen, O.D., Jensen, J., Petersen, H.V., Pedersen, E.E., Oster, A., Andersen, F.G., Jørgensen, M.C., Jensen, P.B., Larsson, L.I., Serup, P. Horm. Metab. Res. (1997) [Pubmed]
  19. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Serup, P., Jensen, J., Andersen, F.G., Jørgensen, M.C., Blume, N., Holst, J.J., Madsen, O.D. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  20. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor. Powers, A.C., Efrat, S., Mojsov, S., Spector, D., Habener, J.F., Hanahan, D. Diabetes (1990) [Pubmed]
  21. Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells. Kataoka, K., Shioda, S., Ando, K., Sakagami, K., Handa, H., Yasuda, K. J. Mol. Endocrinol. (2004) [Pubmed]
  22. Treatment of necrolytic migratory erythema in glucagonoma syndrome. Shepherd, M.E., Raimer, S.S., Tyring, S.K., Smith, E.B. J. Am. Acad. Dermatol. (1991) [Pubmed]
  23. Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas. Møller, C.J., Christgau, S., Williamson, M.R., Madsen, O.D., Niu, Z.P., Bock, E., Baekkeskov, S. Mol. Endocrinol. (1992) [Pubmed]
  24. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. Scopsi, L., Gullo, M., Rilke, F., Martin, S., Steiner, D.F. J. Clin. Endocrinol. Metab. (1995) [Pubmed]
  25. Multiple hormone secretion by a human pancreatic glucagonoma in culture. White, A., Tan, K., Gray, C., Roberts, I., Ratcliffe, J.G. Regul. Pept. (1985) [Pubmed]
  26. Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms. Tomita, T. Pathology. (2004) [Pubmed]
  27. Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription. Ritz-Laser, B., Gauthier, B.R., Estreicher, A., Mamin, A., Brun, T., Ris, F., Salmon, P., Halban, P.A., Trono, D., Philippe, J. Diabetologia (2003) [Pubmed]
  28. Glucagonoma syndrome. Bloom, S.R., Polak, J.M. Am. J. Med. (1987) [Pubmed]
  29. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma. Valverde, I., Lemon, H.M., Kessinger, A., Unger, R.H. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
  30. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. Iwakura, H., Hosoda, K., Doi, R., Komoto, I., Nishimura, H., Son, C., Fujikura, J., Tomita, T., Takaya, K., Ogawa, Y., Hayashi, T., Inoue, G., Akamizu, T., Hosoda, H., Kojima, M., Kangawa, K., Imamura, M., Nakao, K. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  31. Neurologic involvement in glucagonoma syndrome: response to combination chemotherapy with 5-fluorouracil and streptozotocin. Khandekar, J.D., Oyer, D., Miller, H.J., Vick, N.A. Cancer (1979) [Pubmed]
WikiGenes - Universities